首页> 美国卫生研究院文献>BMC Nephrology >Angiopoietin-1 treated early endothelial outgrowth cells (eEOCs) are activated in vitro and reduce renal damage in murine acute ischemic kidney injury (iAKI)
【2h】

Angiopoietin-1 treated early endothelial outgrowth cells (eEOCs) are activated in vitro and reduce renal damage in murine acute ischemic kidney injury (iAKI)

机译:Angiopoietin-1处理的早期内皮生长细胞(eEOCs)在体外被激活并减少了小鼠急性缺血性肾损伤(iAKI)中的肾脏损伤

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundAcute kidney injury (AKI) severely worsens prognosis of hospitalized patients. Early Endothelial Outgrowth Cells act protective in murine acute ischemic renal failure and renoprotective actions of eEOCs have been documented to increase after cell pretreatment with 8-O-cAMP and Melatonin. Angiopoietin-1 is critically involved in maintaining vascular integrity and regeneration. Aim of the study was to analyze the consequences of eEOC treatment with Ang-1 in murine AKI.
机译:背景急性肾损伤(AKI)严重恶化了住院患者的预后。早期内皮细胞生长在鼠急性缺血性肾衰竭中起保护作用,据报道,在用8-O-cAMP和褪黑素预处理细胞后,eEOC的肾脏保护作用增强。血管生成素-1在维持血管完整性和再生中至关重要。该研究的目的是分析用Ang-1进行eEOC治疗对小鼠AKI的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号